glp 1 agonists reduce inflammation Antiinflammatory actions of glucagon-like peptide-1–based therapies beyond metabolic benefits Weight Loss & Treatment |
Description
Biochem Pharmacol
It turns out that insulin secretion is enhanced by a multi-process mechanism [1]
Also, data analysis showed that the serum GLP-1 level of patients with newly diagnosed T2DM combined with CAS was significantly reduced compared with the control group
10.1016/j.cmet.2006.01.004 [DOI] [PubMed] [Google Scholar] 12.Sesti G, Avogaro A, Belcastro S, Bonora BM, Croci M, Daniele G, et al
